The federal contract IDV award is for the supply of nuclear medicine radiopharmaceuticals to the Department of Veterans Affairs (VA), particularly to VA medical facilities in the VA Integrated Service Network 2 region. The prime contractor, Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., has been awarded a single-award IDV contract valued up to $714,324.27, with a period of performance through September 3, 2027. Under this IDV, Cardinal Health 414 will provide a range of...
The federal contract IDV award is for the provision of radiopharmaceuticals to the Department of Veterans Affairs (VA) Veterans Health Administration. The prime contractor is Cardinal Health 414, LLC, a subsidiary of the global healthcare company Cardinal Health, Inc. The contract does not have a set-aside designation and is a single-award, indefinite delivery contract with a ceiling value of $1,994,610.10 and a period of performance through April 30, 2026. The task orders issued under this...
The federal contract IDV award is for an Indefinite Delivery Contract (IDC) between the Department of Veterans Affairs (VA) and Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract, valued at $510,185.95, is for the supply of radiopharmaceuticals to support nuclear medicine, oncology, and diagnostic imaging services at VA medical centers nationwide. Cardinal Health 414 is a major supplier of radiopharmaceuticals, radioactive isotopes, and specialty pharmaceuticals to...
This federal contract IDV award, valued at up to $1,300,000.00, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2) to Cardinal Health 414, LLC, a subsidiary of the global healthcare company Cardinal Health, Inc. The contract is for the delivery of nuclear medicine radiopharmaceuticals, including isotopes such as technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, to VA medical centers,...
The federal contract IDV award is an Indefinite Delivery Contract valued at up to $6,950,000.00 that was awarded by the U.S. Department of Veterans Affairs' Veterans Integrated Service Network 21 (VISN 21) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the provision of radiopharmaceuticals to support nuclear medicine programs at VA healthcare facilities. The contract has an overall performance period from April 1, 2025, to March 31, 2030. Under this IDV, a...
The federal contract IDV is a Blanket Purchase Agreement (BPA) awarded by the Veterans Integrated Service Network 23 (VISN 23), a division of the U.S. Department of Veterans Affairs (VA), to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The BPA is valued at $1,306,265.77 and has an ultimate completion date of March 31, 2030. Under this contract, Cardinal Health 414, LLC is required to provide a variety of radiopharmaceutical products as requested by authorized VA staff in order...
The federal contract IDV awarded by the Department of Veterans Affairs Veterans Health Administration (VA-VHA) to Cardinal Health 414, LLC is for the provision of radiopharmaceuticals. Cardinal Health 414, LLC is a subsidiary of Cardinal Health, Inc., a global healthcare services company. The $1,877,644.52 IDV has a period of performance through September 30, 2025 and allows for ongoing deliveries of a wide range of radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, and...
This federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) held by Cardinal Health 108, LLC, a subsidiary of Cardinal Health, Inc., to provide radiopharmaceuticals for nuclear medicine treatments to the Department of Veterans Affairs (VA) Veterans Integrated Service Network 20 (VISN 20). The contract has a total ceiling value of $2,164,568.67 and a period of performance from November 1, 2024, to October 31, 2029. The initial $198,946.53 firm fixed-price delivery order...
The federal contract IDV award N6264520D5002 is for the delivery of radiopharmaceutical supplies to the Defense Health Agency (DHA), a component of the Department of Defense. The prime contractor, Cardinal Health 414, LLC, a subsidiary of the global healthcare company Cardinal Health, Inc., has been awarded multiple delivery order contracts valued up to $5.5 million through September 2024 under this IDV to provide a range of radiopharmaceuticals, radioactive isotopes, and specialty...
The federal contract IDV award, valued at $1,359,373.23, was granted to Cardinal Health 414, LLC, a subsidiary of the global healthcare company Cardinal Health, Inc. The contract, awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 16, is for the provision of radiopharmaceutical supplies to support the VA's nuclear medicine, oncology, and diagnostic imaging programs. The task order issued under this IDV, valued at $246,012.64, is for the delivery of...
The federal contract IDV award is for the supply of radiopharmaceuticals, radioactive isotopes, diagnostic imaging agents, and specialty pharmaceuticals to support nuclear medicine, oncology, and other patient care programs at facilities operated by the Department of Veterans Affairs (VA), Department of Defense (DOD), and National Institutes of Health (NIH). The prime contractor is Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., a major supplier of medical products to the U.S. government.
The IDV contract, valued up to $1,765,061.02, was awarded by the VA Veterans Integrated Service Network 19 and does not have a set-aside designation. It includes multiple task orders for the delivery of radiopharmaceuticals such as technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67 to VA facilities in Dublin, Ohio. The contract performance period extends through September 2025, allowing the VA to ensure a reliable supply of these essential but short-lived medical tracers to support its healthcare services for veterans.